These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10949326)

  • 41. Completion of therapy for latent tuberculosis in children of different nationalities.
    Powell DA; Perkins L; Wang SH; Hunt G; Ryan-Wenger N
    Pediatr Infect Dis J; 2008 Mar; 27(3):272-4. PubMed ID: 18277917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Childhood tuberculosis: treatment strategies and recent advances.
    Starke JR
    Paediatr Respir Rev; 2001 Jun; 2(2):103-12. PubMed ID: 12531056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment outcome of Singapore residents with pulmonary tuberculosis in the first year after introduction of a computerised treatment surveillance module.
    Chee CB; Wang YT; Teleman MD; Boudville IC; Chew SK
    Singapore Med J; 2006 Jun; 47(6):529-33. PubMed ID: 16752023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utilization of and barriers to public sector tuberculosis services in India.
    Dandona R; Dandona L; Mishra A; Dhingra S; Venkatagopalakrishna K; Chauhan LS
    Natl Med J India; 2004; 17(6):292-9. PubMed ID: 15736548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Movement of tuberculosis patients and the failure to complete antituberculosis treatment.
    Cummings KC; Mohle-Boetani J; Royce SE; Chin DP
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1249-52. PubMed ID: 9563747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Harlem family model: a unique approach to the treatment of tuberculosis.
    el-Sadr W; Medard F; Dickerson M
    J Public Health Manag Pract; 1995; 1(4):48-51. PubMed ID: 10186641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tuberculosis treatment outcome monitoring in England, Wales and Northern Ireland for cases reported in 2001.
    Antoine D; French CE; Jones J; Watson JM
    J Epidemiol Community Health; 2007 Apr; 61(4):302-7. PubMed ID: 17372289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of failure in timely tuberculosis treatment completion, United States.
    Mitruka K; Winston CA; Navin TR
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1075-82. PubMed ID: 22668774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment Outcomes of Patients with Tuberculosis in New York City.
    Bhavnani D; Lancki N; Winter I; Macaraig M
    J Public Health Manag Pract; 2015; 21(6):E11-8. PubMed ID: 25551205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuberculosis in Tennessee: preparing for the 21st century.
    Mehta JB; Inman W; Roy TM
    Tenn Med; 1997 Apr; 90(4):135-7. PubMed ID: 9088150
    [No Abstract]   [Full Text] [Related]  

  • 51. [Investigation of a new treatment outcome index for tuberculosis].
    Ito K
    Kekkaku; 2014 Sep; 89(9):731-6. PubMed ID: 25730944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy and the practical delivery of treatment programs: discussion.
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():121-30. PubMed ID: 4467980
    [No Abstract]   [Full Text] [Related]  

  • 53. Chemotherapy and the practical delivery of treatment programs: discussion.
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():144-51. PubMed ID: 4467984
    [No Abstract]   [Full Text] [Related]  

  • 54. Alarming non-compliance to antituberculosis chemotherapy.
    Ansari G; Shaikh TQ; Memon M
    J Pak Med Assoc; 1988 Nov; 38(11):284-5. PubMed ID: 3148749
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment with tuberculostatic drugs: compliance at a general hospital].
    Polo Friz H; Kremer L; Acosta H; Abdala O; Canova S; Rojo S; Roca G; Daín A
    Rev Fac Cien Med Univ Nac Cordoba; 1997; 55(1-2):21-5. PubMed ID: 10436613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessment of tuberculosis treatment completion in an ethnically diverse population using two data sources. Implications for treatment interventions.
    Morisky DE; Ebin VJ; Malotte CK; Coly A; Kominski G
    Eval Health Prof; 2003 Mar; 26(1):43-58. PubMed ID: 12629921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A patient education program to improve adherence rates with antituberculosis drug regimens.
    Morisky DE; Malotte CK; Choi P; Davidson P; Rigler S; Sugland B; Langer M
    Health Educ Q; 1990; 17(3):253-67. PubMed ID: 2228629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tracing as part of tuberculosis control in a rural Cambodian district during 1992.
    Kimerling ME; Petri L
    Tuber Lung Dis; 1995 Apr; 76(2):156-9. PubMed ID: 7780098
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of discriminant analysis for improving treatment completion in District Tuberculosis Programme.
    Samuel GE
    Indian J Public Health; 1976; 20(1):21-4. PubMed ID: 1022702
    [No Abstract]   [Full Text] [Related]  

  • 60. Notes from the Field: Supply Interruptions of First- and Second-Line Oral Drugs to Treat Tuberculosis During the Previous 12 Months - California, January-March, 2023.
    Nabity SA; Agraz-Lara R; Bravo A; Benjamin R; Fong V; Lam CK; Keh C; Mase S; Flood J
    MMWR Morb Mortal Wkly Rep; 2024 Jan; 72(5253):1390-1391. PubMed ID: 38175801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.